RU2002135599A - METHOD FOR INCREASING ANTIOXIDITIVE POTENTIAL OF SELENOUS CONTAINING AQUEOUS SOLUTIONS - Google Patents

METHOD FOR INCREASING ANTIOXIDITIVE POTENTIAL OF SELENOUS CONTAINING AQUEOUS SOLUTIONS

Info

Publication number
RU2002135599A
RU2002135599A RU2002135599/15A RU2002135599A RU2002135599A RU 2002135599 A RU2002135599 A RU 2002135599A RU 2002135599/15 A RU2002135599/15 A RU 2002135599/15A RU 2002135599 A RU2002135599 A RU 2002135599A RU 2002135599 A RU2002135599 A RU 2002135599A
Authority
RU
Russia
Prior art keywords
selenate
selenite
food
containing aqueous
pharmaceutically acceptable
Prior art date
Application number
RU2002135599/15A
Other languages
Russian (ru)
Other versions
RU2277915C2 (en
Inventor
Петер КЕССЛЕР
Норберт Фукс
Бодо КУКЛИНСКИ
Раймунд ШИФЕР
Original Assignee
Вис-Виталис Лиценц-Унд Хандельс Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0097800A external-priority patent/AT412758B/en
Application filed by Вис-Виталис Лиценц-Унд Хандельс Аг filed Critical Вис-Виталис Лиценц-Унд Хандельс Аг
Publication of RU2002135599A publication Critical patent/RU2002135599A/en
Application granted granted Critical
Publication of RU2277915C2 publication Critical patent/RU2277915C2/en

Links

Claims (12)

1. Способ повышения антиокислительного потенциала селенит- или селенатсодержащих водных растворов, отличающийся тем, что в селенит- или селенатсодержащий водный раствор примешивают лимонную, уксусную, яблочную, угольную кислоты, разные плодовые кислоты или их смеси.1. A method of increasing the antioxidant potential of selenite- or selenate-containing aqueous solutions, characterized in that citric, acetic, malic, malic, carbonic acids, various fruit acids or mixtures thereof are mixed in a selenite- or selenate-containing aqueous solution. 2. Препарат, содержащий фармацевтически приемлемую или совместимую с пищевыми продуктами форму селена в виде селенита или селената, фармацевтически приемлемую или совместимую с пищевыми продуктами кислоту, выбранную из ряда: лимонная, уксусная, яблочная, угольная кислоты, плодовые кислоты и их смеси.2. A preparation containing a pharmaceutically acceptable or food compatible form of selenium in the form of selenite or selenate, a pharmaceutically acceptable or food compatible acid selected from the group: citric, acetic, malic, carbonic acids, fruit acids and mixtures thereof. 3. Препарат по п.2, отличающийся тем, что он содержится в водном растворе при показателе рН менее 7,0, предпочтительно менее 5,0, в частности 3,0-2,5.3. The drug according to claim 2, characterized in that it is contained in an aqueous solution at a pH of less than 7.0, preferably less than 5.0, in particular 3.0-2.5. 4. Препарат по п.2 или 3, отличающийся тем, что он имеет вид геля или эмульсии.4. The drug according to claim 2 or 3, characterized in that it has the form of a gel or emulsion. 5. Препарат по любому из пп.2-4, отличающийся тем, что в нем содержатся в качестве вспомогательных веществ буферные вещества, красители, стабилизаторы, вещества-носители или их сочетания.5. The preparation according to any one of claims 2 to 4, characterized in that it contains buffering agents, dyes, stabilizers, carrier substances or combinations thereof as auxiliary substances. 6. Препарат по любому из пп.2-5, отличающийся тем, что в нем содержатся в качестве дополнительных эффективных компонентов антибиотики, противовирусные, противогрибковые, болеутоляющие или противовоспалительные средства или их сочетания.6. The drug according to any one of paragraphs.2-5, characterized in that it contains as additional effective components antibiotics, antiviral, antifungal, painkillers or anti-inflammatory drugs, or combinations thereof. 7. Препарат по любому из пп.2-6 для фармацевтического применения.7. The drug according to any one of claims 2 to 6 for pharmaceutical use. 8. Применение препарата по любому из пп.2-6 в качестве пищевого продукта или добавки к пищевым продуктам.8. The use of the drug according to any one of claims 2 to 6 as a food product or additive to food products. 9. Применение препарата, включающего селенит- или селенатсодержащий водный раствор с примешанными к нему фармацевтически приемлемыми или совместимыми с пищевыми продуктами кислотами, для получения лекарства для профилактики или лечения заболеваний, вызываемых пероксидами.9. The use of a preparation comprising a selenite- or selenate-containing aqueous solution with pharmaceutically acceptable or food-compatible acids mixed with it, for the manufacture of a medicament for the prevention or treatment of diseases caused by peroxides. 10. Применение препарата, включающего селенит- или селенатсодержащий водный раствор с примешанными к нему фармацевтически приемлемыми или совместимыми с пищевыми продуктами кислотами, для получения лекарства для профилактики или лечения заболеваний, вызываемых свободными радикалами.10. The use of a preparation comprising a selenite or selenate-containing aqueous solution with pharmaceutically acceptable or food-compatible acids mixed with it, for the manufacture of a medicament for the prevention or treatment of diseases caused by free radicals. 11. Применение препарата, включающего селенит- или селенатсодержащий водный раствор с примешанными к нему фармацевтически приемлемыми или совместимыми с пищевыми продуктами кислотами, для получения лекарства для профилактики или лечения вирусных заболеваний, преимущественно инфекций герпеса, в частности инфекций пузырькового лишая.11. The use of a preparation comprising a selenite or selenate-containing aqueous solution with pharmaceutically acceptable or food-compatible acids mixed with it, for the manufacture of a medicament for the prophylaxis or treatment of viral diseases, mainly herpes infections, in particular infections of vesicular lichen. 12. Применение препарата, включающего селенит- или селенатсодержащий водный раствор с примешанными к нему фармацевтически приемлемыми или совместимыми с пищевыми продуктами кислотами, для получения лекарства для профилактики или лечения пигментных пятен.12. The use of a preparation comprising a selenite or selenate-containing aqueous solution with pharmaceutically acceptable or food compatible acids mixed with it, for the manufacture of a medicament for the prevention or treatment of age spots.
RU2002135599/15A 2000-06-05 2001-05-23 Method of raising antioxidant potential of selenium-containing aqueous solutions RU2277915C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0097800A AT412758B (en) 2000-06-05 2000-06-05 USE OF A SELENICITY SOLUTION TO TREAT VIRAL DISEASES
ATA978/2000 2000-06-05

Publications (2)

Publication Number Publication Date
RU2002135599A true RU2002135599A (en) 2004-05-10
RU2277915C2 RU2277915C2 (en) 2006-06-20

Family

ID=3683775

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002135599/15A RU2277915C2 (en) 2000-06-05 2001-05-23 Method of raising antioxidant potential of selenium-containing aqueous solutions

Country Status (11)

Country Link
US (1) US20030180387A1 (en)
EP (1) EP1286675B8 (en)
AT (1) AT412758B (en)
AU (2) AU6363301A (en)
CA (1) CA2411582C (en)
DE (1) DE50107692D1 (en)
DK (1) DK1286675T3 (en)
ES (1) ES2249441T3 (en)
RU (1) RU2277915C2 (en)
WO (1) WO2001093910A2 (en)
ZA (1) ZA200209478B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT412448B (en) * 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels USE OF SEXY PREPARATIONS
AT412703B (en) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels USE OF SELIGENICAL PREPARATIONS FOR TOPICAL OR BUCCAL USE
HU227588B1 (en) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Antiviral and immunostimulant pharmaceutical composition containing polyunsaturated fatty acid esters
FR2923358A1 (en) * 2008-11-03 2009-05-15 Olivier Roujansky Food composition, useful for strengthening immunity to fight against chronic viral diseases, comprises meat/fish, vegetable oil containing alpha-linolenic acid, sodium chloride, potassium, water, and selenium
FR2934119A1 (en) * 2009-07-06 2010-01-29 Olivier Claude Alain Roujansky Food composition, useful e.g. for maintaining latency state of infection due to herpes simplex virus, comprises egg white, vegetable oil containing omega linolenic acid, sodium chloride, potassium salt, water, selenium and soy lecithin
AT511159A1 (en) 2011-02-16 2012-09-15 Selo Medical Gmbh PHARMACEUTICAL COMPOSITIONS CONTAIN SELENIC OR SELENATE COMPOUNDS
US10339933B2 (en) 2016-05-11 2019-07-02 International Business Machines Corporation Visualization of audio announcements using augmented reality
EP3616693A1 (en) 2018-08-28 2020-03-04 Selo Medical GmbH Therapy of high-risk human papillomavirus infections
EP3875083A1 (en) 2020-03-03 2021-09-08 Selo Medical GmbH Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
CN112385761A (en) * 2020-11-18 2021-02-23 深圳市名之洋生物科技有限公司 Selenium-enriched water and preparation method thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340590A (en) * 1977-08-02 1982-07-20 Lundy Research Laboratories, Inc. Method for reducing or inhibiting ecchymosis in skin tissues with inorganic selenium compositions
IT1161213B (en) * 1983-03-08 1987-03-18 Fcn Srl PHARMACEUTICAL COMPOSITIONS WITH ANTINEOPLASTIC ACTIVITY
US4762726A (en) * 1983-12-30 1988-08-09 Kraft, Inc. Shelf stable acid food dressings containing fibrous protein complexes
US4668515A (en) * 1984-03-06 1987-05-26 Paul Bankit Method and compositions for sodium selenite administration
DE3929411A1 (en) * 1988-09-22 1990-03-29 Siegfried Natterer Pharmaceutical preparation and process for its preparation
DE69303813T2 (en) * 1992-03-11 1997-01-16 The Procter & Gamble Co., Cincinnati, Ohio GRAINED PRINCIPLES CONTAINING PSYLLIUM BEVERAGE COMPOSITIONS
US5425944A (en) * 1992-10-27 1995-06-20 Harich; Jakob Antimicrobial grapefruit extract
DE4335441A1 (en) * 1993-10-18 1995-04-20 Hans Dipl Chem Heide Preventive medical composition for the human cardiovascular system
US5512200A (en) * 1994-04-18 1996-04-30 Thomas G. Bongard Low pH Acidic Compositions
DE4413839C1 (en) * 1994-04-21 1995-10-19 Fritz Koch Pharma Gmbh Dr Med Prepn. to protect human bodies from oxidative processes
DE4437403A1 (en) * 1994-10-19 1996-04-25 Mann Gerhard Chem Pharm Fab Antioxidant for protecting human cells from damage by free radicals
GB2323030A (en) * 1997-03-12 1998-09-16 Essential Nutrition Ltd Dietary supplements for immunocompromised patients
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
AT412703B (en) * 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels USE OF SELIGENICAL PREPARATIONS FOR TOPICAL OR BUCCAL USE

Similar Documents

Publication Publication Date Title
US6403116B1 (en) Coenzyme Q10 formulation
CA2122612A1 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
TW366286B (en) Flavour-masked pharmaceutical compositions
EP1283054A4 (en) Drugs for complications of diabetes and neuropathy and utilization thereof
RU2009126735A (en) COMPOSITION OF NUTRITIONAL SUPPLEMENT FOR THE TREATMENT OF EYE DISEASES
RU2002135599A (en) METHOD FOR INCREASING ANTIOXIDITIVE POTENTIAL OF SELENOUS CONTAINING AQUEOUS SOLUTIONS
US11903978B2 (en) Non-winterized, standardized marine source oil products and methods of making thereof
KR940018089A (en) Prevention and treatment for radiation damage of internal tissue
ES2032681T3 (en) AN ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION, WITH ELIMINATION, IN SOLUTION, OF BITTER TASTE, BURNING OF THE THROAT AND INTESTINAL TOXICITY. (RESERVATION OF ART. 167.2 CPE).
CA2468906A1 (en) Use of selenite-containing compounds to be topically or buccally administered
JP2024023610A (en) Vitamin b12-containing composition
JP4812968B2 (en) Composition for improving attention deficit / hyperactivity disorder
CA2150234C (en) Combination of atovaquone with proguanil for the treatment of protozoal infections
EP0579155A2 (en) Aqueous preparation of arulene sodium sulfonate
CA2429793A1 (en) Interferon therapeutic effect enhancer
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
US20030109494A1 (en) Ascorbic acid stability
RU2000116660A (en) BIOLOGICALLY ACTIVE FOOD ADDITIVE
JPS6041472A (en) Drink for health and beauty
JPH04120020A (en) Lipid metabolism regulation agent
RU2290837C1 (en) Agent for impotence prophylaxis
RU2141775C1 (en) Composition of ingredients for biologically-active additive to food-stuffs "cherny barkhat"
RU2283661C1 (en) Agent for arteriosclerosis prophylaxis
MD2309B2 (en) Process for production of natural sparkling wine
US20060093676A1 (en) Ascorbic acid stability